Valuation: Pfizer Inc.

Market Cap 158B 137B 130B 118B 221B 15,128B 222B 1,555B 600B 7,691B 592B 579B 24,747B P/E 2026 *
17.4x
P/E 2027 * 13.5x
Enterprise Value 205B 179B 169B 153B 287B 19,684B 289B 2,023B 781B 10,008B 771B 753B 32,200B EV / Sales 2026 *
3.3x
EV / Sales 2027 * 3.32x
Free-Float
59.05%
Yield 2026 *
6.22%
Yield 2027 * 6.27%
1 day+0.07%
1 week-0.22%
Current month-2.81%
1 month-2.05%
3 months+9.72%
6 months+0.91%
Current year+11.08%
1 week 27.24
Extreme 27.245
28.19
1 month 27.24
Extreme 27.245
29.21
Current year 23.62
Extreme 23.62
29.21
1 year 23.58
Extreme 23.58
29.21
3 years 20.92
Extreme 20.915
34.11
5 years 20.92
Extreme 20.915
61.71
10 years 20.92
Extreme 20.915
61.71
Manager TitleAgeSince
Chief Executive Officer 64 2018-12-31
Director of Finance/CFO 55 2026-08-15
Compliance Officer 65 2013-11-30
Director TitleAgeSince
Director/Board Member 68 2007-08-31
Director/Board Member 62 2013-09-26
Chairman 64 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/15/26 Free

Chief Executive Officer

22 0.0000%
8/31/26 Free

Chief Executive Officer

21 0.0000%
8/17/26 Other

Chief Financial Officer

273,464 0.0048%
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-0.22%+15.11%-18.62% 158B
+0.04%+3.34%+53.32%+100.52% 1,028B
-0.09%+1.66%+53.24%+66.45% 651B
-0.02%+2.66%+18.65%+71.97% 466B
-1.22%+3.66%+34.59%+38.81% 346B
-0.79%+2.73%+17.73%+25.11% 266B
+0.58%+6.76%+10.58%+17.75% 259B
+1.55%+2.20%+35.12%+45.91% 208B
+0.79%+1.84%-27.55%-56.48% 191B
-0.52%+4.45%+31.57%+98.11% 186B
Average +0.04%+2.91%+24.24%+38.95% 375.94B
Weighted average by Cap. -0.03%+2.95%+34.02%+58.24%

Financials

2026 *2027 *
Net sales 62.24B 54.27B 51.24B 46.53B 87.18B 5,972B 87.55B 614B 237B 3,036B 234B 229B 9,769B 59.77B 52.12B 49.21B 44.69B 83.72B 5,735B 84.07B 589B 227B 2,916B 225B 220B 9,382B
Net income 8.9B 7.76B 7.33B 6.65B 12.47B 854B 12.52B 87.78B 33.88B 434B 33.43B 32.69B 1,397B 11.08B 9.66B 9.12B 8.28B 15.52B 1,063B 15.59B 109B 42.17B 541B 41.62B 40.7B 1,739B
Net Debt 47.48B 41.41B 39.1B 35.5B 66.52B 4,556B 66.8B 468B 181B 2,316B 178B 174B 7,454B 40.98B 35.73B 33.74B 30.64B 57.41B 3,932B 57.65B 404B 156B 1,999B 154B 151B 6,433B
Logo Pfizer Inc.
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (42.9%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (28%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (26.9%); - other (2.2%). The United States accounts for 59.2% of net sales.
Employees
75,000
Date Price Change Volume
26-09-18 US$27.66 +0.07% 75,593,387
26-09-17 US$27.64 +0.66% 29,013,808
26-09-16 US$27.46 -0.33% 26,046,156
26-09-15 US$27.55 -0.61% 40,435,888
26-09-14 US$27.72 0.00% 28,571,580
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
27.66USD
Average target price
28.88USD
Spread / Average Target
+4.39%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!